Found 19 matching trials
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion NA Acute ischemic stroke (AIS) due to medium vessel occlusion (MeVO) or severe...
Show More Location
Fu Yang People's Hospital
Learn More & Join Trial
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion PHASE3 The purpose of this study is to investigate the safety and efficacy of endo...
Show More Location
The First Affiliated Hospital of USTC
Learn More & Join Trial
Boosting REcanalization of Thrombectomy for Ischemic Stroke by Intra-arterial TNK (BRETIS-TNK) NA Thrombolysis and endovascular thrombectomy are the most efficient treatment...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Improving Neuroprotective Strategy for Ischemic Stroke With Poor Recanalization After Thrombectomy by Intra-arterial TNK (INSIST-TNK) NA In 2015, five randomized trials showed efficacy of endovascular thrombectom...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke PHASE3 The ANGEL-MeVO-TNK is a multicentered, prospective, randomized, open label,...
Show More Location
Beijing Tiantan Hospital, Capital Medical University
Learn More & Join Trial
Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion PHASE2 Recent studies revealed the safety and effectiveness of EVT in patients wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke N/A Since 2015, many randomized trials have shown that endovascular thrombectom...
Show More Location
Xiangtan Central Hospital
Learn More & Join Trial
Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion PHASE3 Study purpose:
A multicenter, prospective, randomized, open-label, blinded...
Show More Location
the First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization PHASE4 The goal of this clinical trial is to evaluate whether intra-arterial (IA) ...
Show More Location
Beijing Tiantan Hospital, Capital Medical University
Learn More & Join Trial
Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions PHASE3 TECNO is a multicenter, prospective, randomized, open label, blinded endpoi...
Show More Location
LKH-Universitätsklinikum Graz
Learn More & Join Trial